Introduction to Nervous and Endocrine Systems — BME Study Guide

1. Learning Objectives

By the end of this unit, the student should be able to:

1Describe the structural organisation of the nervous system (CNS, PNS, autonomic divisions).

2Explain the ionic basis of the resting membrane potential and the action potential using the Nernst and Goldman equations.

3Model the neuronal membrane as an RC electrical circuit (Hodgkin–Huxley framework).

4Compare electrical and chemical synaptic transmission and their engineering analogies.

5Identify the major endocrine glands and the hormones they secrete, with target organs and functions.

6Analyse negative and positive feedback loops as biological control systems (block-diagram representation).

7Explain glucose homeostasis and relate it to diabetes mellitus and biosensor/closed-loop insulin-pump design.

8Relate nervous and endocrine signalling to biomedical devices: EEG/ECoG, neural prostheses, defibrillation, hormone assays, and the artificial pancreas.

2. Overview: The Body's Two Communication Networks

The human body coordinates billions of cells using two complementary communication systems. Understanding both is essential for the biomedical engineer, because nearly every diagnostic and therapeutic device interfaces with one — or both — of these systems.

Feature	Nervous System	Endocrine System
Signalling agent	Action potentials (electrical) + neurotransmitters (chemical)	Hormones (chemical only)
Speed	Fast — milliseconds (up to ~120 m/s in myelinated fibres)	Slow — seconds to hours/days
Duration	Short-lived, localised	Long-lasting, widespread
Pathway	Wired (dedicated neurons)	Wireless (bloodstream / diffusion)
Target specificity	Synapse-to-synapse (precise)	Any cell with the right receptor
Engineering analogy	Digital bus / point-to-point cable with packet switching	Broadcast radio / message flooding
BME interface examples	EEG electrodes, pacemakers, deep-brain stimulators, cochlear implants	Glucose biosensors, insulin pumps, immunoassays, hormone drug delivery

Key insight for engineers: The nervous system is a high-speed, low-latency, event-driven digital-ish network, while the endocrine system is a low-speed, amplitude-modulated analogue broadcast network. Medical devices must be designed to match each system's signalling conventions.

3. The Nervous System: Structure and Organisation

3.1 Anatomical Divisions

Central Nervous System (CNS): brain and spinal cord — integration and command centre, protected by the skull, vertebral column, meninges, and blood–brain barrier.
Peripheral Nervous System (PNS): cranial and spinal nerves connecting the CNS to the body. Divided into:
- Afferent (sensory) division — carries signals to the CNS (receptors → CNS).
- Efferent (motor) division — carries commands from the CNS to effectors:
  - Somatic nervous system — voluntary control of skeletal muscle.
  - Autonomic nervous system (ANS) — involuntary control of smooth muscle, cardiac muscle, and glands:
    - Sympathetic — "fight or flight"; increases heart rate, dilates pupils, mobilises glucose.
    - Parasympathetic — "rest and digest"; slows heart rate, stimulates digestion, conserves energy.

3.2 The Neuron — the System's Fundamental Cell

Figure 1. The multipolar neuron — the fundamental processing and signalling unit of the nervous system.

Structure	Function	Engineering analogy
Dendrites	Receive incoming signals from other neurons	Antenna / input port
Cell body (soma)	Integration; metabolic centre	Summing amplifier / processor
Axon hillock	Trigger zone where action potentials are initiated if threshold is reached	Comparator with threshold (Schmitt trigger)
Axon	Conducts action potentials to target	Transmission line
Myelin sheath (Schwann cells / oligodendrocytes)	Electrical insulation → saltatory conduction, ↑ velocity, ↓ energy cost	Coaxial cable dielectric
Synaptic terminals	Convert electrical signal to chemical release	Digital-to-analogue converter / RF front-end

3.3 Glial Cells — the "Support Electronics"

Astrocytes: blood–brain barrier support, ion (K⁺) buffering, neurotransmitter uptake.
Oligodendrocytes (CNS) / Schwann cells (PNS): produce myelin.
Microglia: immune defence of the CNS.
Ependymal cells: line ventricles; produce cerebrospinal fluid (CSF).

BME relevance: Glial scarring around implanted electrodes is a major cause of chronic neural-implant signal degradation — a key design challenge for brain–computer interfaces (BCIs).

4. Membrane Potential and the Action Potential

4.1 The Resting Membrane Potential (~ −70 mV)

Neurons maintain a voltage difference across their membrane because of:

Ion gradients maintained by the Na⁺/K⁺-ATPase pump (3 Na⁺ out, 2 K⁺ in per ATP).
Selective permeability — leak channels make the membrane ~50–100× more permeable to K⁺ than Na⁺ at rest.
Impermeant intracellular anions (proteins, phosphates) that trap positive charge outside.

Nernst equation (equilibrium potential for ion X): E_X = (RT / zF) · ln([X]_out / [X]_in)

At 37 °C, with log₁₀ and z = +1: E_X ≈ 61.5 log₁₀([X]_out/[X]_in) mV. Typical values: E_K ≈ −90 mV, E_Na ≈ +60 mV, E_Cl ≈ −65 mV.

Goldman–Hodgkin–Katz equation (multi-ion resting potential): V_m = 61.5 log₁₀ ( (P_K[K⁺]_out + P_Na[Na⁺]_out + P_Cl[Cl⁻]_in) / (P_K[K⁺]_in + P_Na[Na⁺]_in + P_Cl[Cl⁻]_out) ) mV

4.2 The Neuron as an RC Circuit

The lipid bilayer is a capacitor (C_m ≈ 1 μF/cm²); ion channels are conductances (g) in series with batteries (E_ion); the pump is a current source. The membrane time constant τ = R_mC_m (typically 1–20 ms) sets how fast voltage changes, and the length constant λ = √(R_m/R_i) sets how far passive signals spread — the basis of cable theory used to model dendrites and axons.

Hodgkin–Huxley current balance: C_m dV/dt = I_ext − g_Na(V−E_Na) − g_K(V−E_K) − g_L(V−E_L)

_m g_Na E_Na (+60 mV) Equivalent circuit of the neuronal membrane

Figure 2. Membrane equivalent circuit: capacitor in parallel with ionic conductance–battery branches.

4.3 The Action Potential — Phases

Figure 3. The action potential. An "all-or-none" regenerative pulse propagating along the axon without attenuation (decrement).

Phase	Membrane events	Ionic basis
Resting state	V_m ≈ −70 mV	High K⁺ permeability; Na⁺ channels closed
Depolarisation (rising)	V_m rises past 0 to ≈ +30 mV	Voltage-gated Na⁺ channels open; Na⁺ rushes in (drives V toward E_Na)
Repolarisation (falling)	V_m returns toward resting	Na⁺ channels inactivate; voltage-gated K⁺ channels open; K⁺ leaves
Hyperpolarisation (undershoot)	V_m dips below −70 mV (≈ −90 mV)	K⁺ channels slow to close; membrane approaches E_K
Refractory periods	Absolute: no new AP possible; Relative: stronger stimulus needed	Na⁺ channel inactivation (absolute); K⁺ still open (relative)

All-or-none law: Once threshold (≈ −55 mV) is crossed, the action potential fires with a fixed amplitude — information is encoded in frequency and timing, not amplitude (frequency modulation, not amplitude modulation!).

4.4 Conduction Velocity and Saltatory Conduction

Approximate velocity: v ≈ k · d (k ≈ 5.5 for unmyelinated, k ≈ 17 for myelinated fibres; d = diameter in μm, v in m/s)

Myelin forces the action potential to "jump" between Nodes of Ranvier — saltatory conduction — increasing velocity up to ~120 m/s and reducing metabolic energy per impulse. Demyelinating diseases (e.g., multiple sclerosis) slow or block conduction — measurable clinically as increased nerve-conduction latency.

BME relevance: Nerve conduction velocity (NCV) studies and electromyography (EMG) are standard electrodiagnostic tools. Their instrumentation — differential amplifiers, band-pass filtering (EMG ~20–500 Hz), stimulation isolation — is classic biomedical signal processing.

5. Synaptic Transmission

5.1 Electrical Synapses (Gap Junctions)

Direct ionic current flow through connexon channels; bidirectional, very fast (~0.1 ms delay), synchronising (e.g., cardiac muscle, retinal cells).
Engineering analogy: hard-wired bus with negligible latency.

5.2 Chemical Synapses

Action potential arrives at the presynaptic terminal.
Voltage-gated Ca²⁺ channels open → Ca²⁺ influx.
Ca²⁺ triggers synaptic vesicle fusion (SNARE proteins) → neurotransmitter release into the cleft (~20–40 nm).
Transmitter binds postsynaptic receptors → ion channels open (direct/ionotropic) or second messengers activated (indirect/metabotropic).
Signal terminated by reuptake, enzymatic degradation, or diffusion.

Neurotransmitter	Type	Major effects	Clinical / BME link
Acetylcholine (ACh)	Excitatory & inhibitory (receptor-dependent)	Neuromuscular junction, autonomic ganglia, cognition	Myasthenia gravis; Alzheimer drugs; anaesthetics
Glutamate	Excitatory (main CNS transmitter)	Learning, memory, fast signalling	Excitotoxicity in stroke; epilepsy
GABA	Inhibitory (main CNS)	Reduces neuronal firing	Benzodiazepines, anaesthetics act here
Dopamine	Modulatory	Reward, movement control	Parkinson's disease (deep brain stimulation target)
Serotonin	Modulatory	Mood, sleep, appetite	SSRIs; depression treatment
Norepinephrine	Modulatory	Arousal, attention, "fight or flight"	Autonomic monitoring; stress biosensors

BME relevance: Most neurological drugs act at synapses, and neural stimulators (DBS for Parkinson's, spinal-cord stimulators for pain, vagus-nerve stimulators for epilepsy) work by electrically overriding pathological synaptic network activity.

6. Bioelectric Signals and Their Measurement

Because ion currents in excitable tissue produce electric and magnetic fields detectable at the body surface, the nervous system can be monitored non-invasively:

Signal	Source	Typical amplitude	Frequency range	Clinical use
EEG	Post-synaptic potentials of cortical neurons	10–100 μV	0.5–45 Hz	Epilepsy, sleep staging, brain death, anaesthesia depth, BCI
ECoG / intracortical	Cortex (surface / depth electrodes)	0.1–5 mV	0.5–500 Hz	Epilepsy surgery mapping, high-resolution BCIs
EMG	Muscle-fibre action potentials	50 μV–5 mV	20–500 Hz	Motor disorders, prosthesis control
ENG / NCV	Peripheral nerve compound APs	μV–mV (evoked)	1–10 kHz	Nerve damage, demyelination

6.1 The 10–20 EEG Electrode System

Standardised scalp placement at 10% / 20% of skull landmarks (nasion–inion, left–right pre-auricular). Electrode pairs form montages; signals are named by region: F (frontal), C (central), P (parietal), O (occipital), T (temporal), with odd numbers = left hemisphere, even = right.

6.2 EEG Rhythms

Band	Frequency	State
Delta (δ)	0.5–4 Hz	Deep sleep; pathological in awake adults
Theta (θ)	4–8 Hz	Drowsiness, light sleep
Alpha (α)	8–13 Hz	Relaxed eyes-closed (occipital)
Beta (β)	13–30 Hz	Alert, active thinking
Gamma (γ)	30–45 Hz	Perception, binding, attention

Measurement challenge: EEG signals are ~100× smaller than ECG interference from mains (50 Hz in Kenya!), so biomedical amplifiers need high CMRR (>100 dB), right-leg/common-mode feedback, shielding, and notch filtering — a classic instrumentation design problem.

7. The Endocrine System

The endocrine system is a set of ductless glands that secrete hormones — chemical messengers transported mainly via the bloodstream to target cells bearing specific receptors. Together with the nervous system it maintains homeostasis.

7.1 Major Endocrine Glands and Hormones

Gland	Hormone(s)	Principal function	Engineering / clinical device link
Hypothalamus	Releasing/inhibiting hormones (TRH, CRH, GnRH, GHRH, somatostatin, dopamine)	Master regulator of the anterior pituitary	Feedback set-point of the hormonal control hierarchy
Anterior pituitary	TSH, ACTH, LH, FSH, GH, PRL	"Trophic" hormones that command peripheral glands	Cascade (hierarchical) control analogy
Posterior pituitary	ADH (vasopressin), oxytocin	Water reabsorption (kidneys); uterine contraction, milk ejection	Diabetes insipidus diagnosis
Thyroid	T3, T4 (thyroxine), calcitonin	Metabolic rate, growth, development	Neonatal TSH screening strips
Parathyroids	PTH	Blood Ca²⁺ regulation (with calcitonin & vitamin D)	Bone-disease monitoring
Adrenal cortex	Cortisol, aldosterone, androgens	Stress response, Na⁺/K⁺ balance, glucose metabolism	Cortisol stress biosensors (research)
Adrenal medulla	Adrenaline (epinephrine), noradrenaline	"Fight or flight" — HR, BP, glucose ↑	Autonomic monitoring; defibrillation response
Pancreatic islets	Insulin (β-cells), glucagon (α-cells), somatostatin (δ-cells)	Blood-glucose homeostasis	Glucose biosensors, insulin pumps, artificial pancreas
Gonads (ovaries/testes)	Estrogen, progesterone / testosterone	Reproduction, secondary sex characteristics	Hormonal contraceptive delivery systems
Pineal	Melatonin	Circadian rhythm / sleep	Light-therapy devices

7.2 Classes of Hormones and Signalling Mechanisms

Class	Examples	Transport	Receptor location	Mechanism	Speed
Peptide / protein	Insulin, GH, TSH, ADH	Free in plasma (hydrophilic)	Cell surface	Second messengers (cAMP, IP₃/DAG, Ca²⁺)	Fast (sec–min)
Steroid	Cortisol, estrogen, testosterone	Bound to carrier proteins	Intracellular (cytoplasm/nucleus)	Gene transcription	Slow (hours–days)
Amine (modified amino acids)	T3/T4, adrenaline, melatonin	Mixed	Mixed	Mixed	Mixed

7.3 Hypothalamus–Pituitary–Target-Gland Cascade

The endocrine system is organised as a hierarchical control system, exactly analogous to a supervisory control architecture in industrial automation:

Figure 4. The hypothalamic–pituitary axis as a closed-loop control system with negative feedback.

8. Feedback Control in Physiology

8.1 Negative Feedback (Stabilising — the dominant mode)

A controlled variable is sensed, compared with a set point, and corrections are applied to reduce the error. Gain, sensors, actuators, and controllers in physiology map directly onto control-theory vocabulary:

Control-system element	Physiological example (blood glucose)	Physiological example (blood pressure)
Sensor (transducer)	Pancreatic β-cells sense glucose	Baroreceptors in carotid sinus & aortic arch
Controller / comparator	Islet-cell signal processing	Medullary cardiovascular centre
Actuator	Insulin / glucagon secretion	Heart rate, contractility, vascular tone (symp./parasymp.)
Plant (controlled process)	Liver, muscle, adipose tissue uptake / release of glucose	Cardiovascular system
Disturbance	Meal (glucose ↑), exercise (glucose ↓)	Posture change, haemorrhage

8.2 Positive Feedback (Amplifying — used sparingly, must be terminated)

Blood clotting: thrombin activates more thrombin generation.
Childbirth (Ferguson reflex): oxytocin → uterine contraction → more oxytocin.
Nerve AP upstroke: Na⁺ influx depolarises, opening more Na⁺ channels.
Defibrillation note: ventricular fibrillation is a pathological positive-feedback loop of re-entrant excitation — terminated by an external electrical shock (defibrillator), a direct BME intervention.

8.3 Feedforward Control

Anticipatory correction before the disturbance affects the output — e.g., cephalic-phase insulin release (insulin secreted when food is smelled/seen, before glucose rises). Faster than feedback but requires a reliable predictor.

9. Case Study: Glucose Homeostasis — Where Endocrine Engineering Lives

9.1 Normal Regulation

Blood glucose rises (e.g., after a meal) → β-cells of pancreatic islets release insulin → liver, muscle and adipose tissue take up glucose; liver converts glucose → glycogen/fat → blood glucose falls back to ~4–6 mM (72–108 mg/dL fasting).
Blood glucose falls (fasting, exercise) → α-cells release glucagon → liver breaks down glycogen and performs gluconeogenesis → glucose rises.

9.2 Diabetes Mellitus — A Control-System Failure

Type	Cause	Typical onset	Treatment principle
Type 1	Autoimmune destruction of β-cells → no insulin (sensor/actuator loss)	Childhood / young adult	Exogenous insulin delivery (open or closed loop)
Type 2	Insulin resistance + progressive β-cell failure (reduced plant gain)	Adult (rising in youth)	Lifestyle, metformin, insulin as disease progresses
Gestational	Pregnancy-induced insulin resistance	Pregnancy	Diet, insulin if needed

Chronic hyperglycaemia damages retina (retinopathy), kidneys (nephropathy), nerves (neuropathy) and cardiovascular tissue — the motivation for tight glucose control technology.

9.3 The Biomedical Engineering Response

Glucose biosensor (1956 concept → 1980s home meters → modern CGMs): enzyme-based electrochemical transducer — glucose oxidase reaction produces H₂O₂ / electrons proportional to glucose concentration. Continuous glucose monitors (CGMs) sample interstitial fluid every 1–5 min.
Insulin pump: programmable micro-infusion actuator replacing bolus injections (open loop with patient input).
Closed-loop "artificial pancreas": CGM → control algorithm (PID, model-predictive control) → pump. Control challenges include sensor lag (interstitial vs blood), meal disturbances, exercise, and actuator latency — a live case study in robust control with safety-critical constraints.

Design brief for discussion: Sketch the block diagram of a closed-loop artificial pancreas. Identify sensor noise, time delays, and saturation limits of the actuator. Which control strategy (PID vs MPC) would you choose and why?

10. Biomedical Engineering Applications Overview

System	Device / Technology	Principle
Nervous	EEG machine	Scalp potential recording; differential amplification
	Pacemaker / ICD	Sense & pace cardiac conduction; defibrillate fibrillation
	Deep brain stimulation	High-frequency pulses override pathological basal-ganglia activity (Parkinson's)
	Cochlear implant	Sound → electrode array stimulating auditory nerve (16–22 channels)
	Brain–computer interface	Motor-cortex signals decoded to control prosthetics/cursors
Endocrine	CGM + insulin pump ("artificial pancreas")	Closed-loop glucose control
	Immunoassay analysers (ELISA, CLIA)	Lab-based hormone measurement via antibody–antigen binding
	Point-of-care hormone tests	Lateral-flow / electrochemical biosensors
	Hormone delivery implants / patches	Controlled-release drug delivery (e.g., contraceptive implants)

11. Nervous vs Endocrine Signalling — Consolidated Comparison

Aspect	Nervous	Endocrine
Message	AP (electrical) + neurotransmitter	Hormone in blood
Latency	~1 ms	Seconds – hours
Range	Target cell at synapse	Whole body (receptor-defined)
Coding	Frequency / timing codes	Concentration (amplitude) code
Recovery	Refractory period	Hormone half-life + degradation
Interaction	Hypothalamus is the physical link: neurosecretory cells convert neural commands into hormonal commands (neuroendocrine transduction).

12. Summary of Key Points

The nervous system is a fast, wired, digital-like signalling network; the endocrine system is a slow, broadcast, analogue-amplitude network; both serve homeostasis.
The resting potential (−70 mV) arises from K⁺-dominant permeability and the Na⁺/K⁺ pump; it is quantified by the Nernst and GHK equations.
The action potential is an all-or-none, regenerative pulse: Na⁺ influx depolarises, K⁺ efflux repolarises; myelin enables saltatory conduction.
The neuronal membrane is an RC circuit; Hodgkin–Huxley formalism remains the foundation of computational neuroscience and neural-interface modelling.
Chemical synapses convert electrical events to chemical messages; most neural drugs and all neural stimulators act here.
Bioelectric signals (EEG, EMG, ENG) are measurable with differential amplifiers — the design constraints (μV levels, 50 Hz mains interference) define front-end specs.
Endocrine glands form a hierarchical control cascade (hypothalamus → pituitary → target gland) closed by negative feedback.
Negative feedback stabilises (glucose, thyroid, BP); positive feedback amplifies and must self-terminate (clotting, labour); feedforward anticipates.
Glucose homeostasis failure (diabetes) has produced one of BME's flagship technologies: the biosensor → pump → closed-loop artificial pancreas.

Exam hint: Be able to draw — (a) the action-potential waveform with ionic events labelled, (b) the neuronal-membrane equivalent circuit, (c) a negative-feedback block diagram of glucose regulation or the HPA axis, and (d) a table of the major endocrine glands, hormones and functions.

13. Glossary of Key Terms

Action potential: Brief, all-or-none reversal of membrane potential that propagates along an excitable cell.
Axon hillock: Region of the soma where graded potentials are summed and, if threshold is reached, an action potential is triggered.
Depolarisation: Reduction in the magnitude of the (negative) membrane potential, moving toward 0 mV.
Endocrine gland: Ductless gland that secretes hormones directly into the bloodstream.
Homeostasis: Maintenance of a stable internal environment via feedback control.
Hormone: Chemical messenger secreted into blood that acts on distant target cells possessing specific receptors.
Hyperpolarisation: Membrane potential becoming more negative than resting potential.
Negative feedback: Control in which the output counteracts the change that produced it, stabilising the variable.
Neurotransmitter: Chemical released at a synapse that transmits the signal to the postsynaptic cell.
Resting membrane potential: Steady voltage (~ −70 mV) across an unstimulated neuronal membrane, inside relative to outside.
Saltatory conduction: Leap-frog propagation of the action potential between Nodes of Ranvier in myelinated axons.
Set point: Reference value of a controlled variable in a feedback loop.
Synapse: Junction between two neurons (or neuron and effector) where signalling occurs.
Trophic hormone: Hormone whose target is another endocrine gland, stimulating its growth and secretion (e.g., TSH, ACTH).

Introduction to the Nervous and Endocrine Systems